3D-Printed Composite Tissue Scaffolds for Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current materials for treating large, critical-sized tissue defects, such as those caused by traumatic injury or disease, face challenges in biocompatibility, mechanical properties, and limited availability, with metallic implants causing corrosion and nonmetallic materials having inadequate mechanical properties and manufacturing difficulties.
Innovation Solution
A three-dimensional tissue scaffold composed of composite materials with insoluble and soluble components, fabricated using rapid prototyping techniques, which creates a unique micro- and nanoporous structure by dissolving the soluble component, supporting various cell types and mimicking native tissue properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If metallic implants are used to treat large tissue defects, then mechanical properties are improved, but biocompatibility deteriorates due to corrosion and toxic ion release
Solution Approach 1:
The patent employs composite materials combining biocompatible polymers (such as PCL, PLA, or PGA) with bioactive ceramic particles (such as hydroxyapatite or tricalcium phosphate) to create scaffolds that simultaneously provide adequate mechanical strength and excellent biocompatibility. The polymer matrix offers flexibility and toughness while the ceramic particles provide bioactivity and osteoconductivity, resolving the contradiction between mechanical properties and biocompatibility.
Solution Approach 2:
The patent utilizes porous scaffold structures with controlled pore sizes and interconnectivity to enable cell infiltration, nutrient transport, and waste removal. The porous architecture reduces material density to improve biocompatibility while maintaining mechanical integrity through optimized strut thickness and spatial arrangement, thereby addressing the contradiction between strength and biocompatibility.
2Object-affected harmful factors
If nonmetallic synthetic materials are used to improve biocompatibility, then biocompatibility is improved, but mechanical properties deteriorate
Solution Approach 1:
The patent combines biocompatible polymers with bioactive ceramic particles to create composite scaffolds where the polymer provides flexibility and the ceramic particles enhance mechanical strength and bioactivity. This composite approach allows the scaffold to achieve both high biocompatibility and adequate mechanical properties for load-bearing tissue regeneration.
Solution Approach 2:
The patent adjusts key parameters including polymer molecular weight, crystallinity, crosslinking density, and ceramic particle size and distribution to optimize the balance between biocompatibility and mechanical strength. By controlling these parameters, the scaffold can be tailored to provide appropriate mechanical support while maintaining excellent biocompatibility for tissue integration.
3Object-affected harmful factors
If inorganic ceramics are used to provide bioactivity, then bioactivity is improved, but mechanical properties and manufacturability deteriorate
Solution Approach 1:
The patent incorporates bioactive ceramic particles (hydroxyapatite, tricalcium phosphate) as fillers within a polymer matrix rather than using pure ceramic. This composite structure leverages the bioactivity of ceramics while the polymer matrix provides flexibility and toughness, achieving both high bioactivity and adequate mechanical properties that pure ceramics cannot provide.
Solution Approach 2:
The patent creates heterogeneous composite structures where bioactive ceramic particles are strategically distributed within the polymer matrix to maximize bioactivity at the tissue interface while maintaining overall mechanical integrity. The local concentration and size of ceramic particles are optimized to provide enhanced bioactivity in critical regions without compromising the bulk mechanical properties.
4Object-affected harmful factors
If autologous grafts are used to ensure biocompatibility, then biocompatibility is improved, but availability deteriorates due to inadequate donor tissue
Solution Approach 1:
The patent creates synthetic scaffold copies that replicate the essential structural and functional characteristics of natural extracellular matrix without requiring autologous tissue. The scaffolds are designed with appropriate porosity, surface topology, and biochemical cues to mimic native tissue architecture, providing a limitless supply of biocompatible graft materials that do not depend on donor site availability.
5Manufacturing precision
If rapid prototyping technology is used to manufacture scaffolds, then manufacturing precision is improved, but the ability to create sub-resolution features deteriorates
Solution Approach 1:
The patent employs a two-stage manufacturing approach where rapid prototyping technology is used to fabricate the macro-scale scaffold geometry with high precision, followed by a secondary process (such as electrospinning, dip-coating, or chemical treatment) to add micro- and nano-scale surface features. This segmentation of manufacturing scales allows each process to optimize for its appropriate resolution level, achieving both macro geometric precision and micro surface functionality.
Solution Approach 2:
The patent designs the rapid prototyping scaffold with preliminary surface features and pore structures that serve as a foundation for subsequent surface modification processes. The macro-structure is pre-formed with appropriate geometry and porosity, then micro- and nano-scale features are added in a preliminary action before biological testing or implantation, ensuring both scales of features are present in the final product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scaffold promotes effective tissue regeneration by providing a biocompatible, customizable structure that supports cell adhesion and growth, addressing the limitations of existing materials and enhancing host-implant integration.
Implementation Method 1
the soluble component of the composite material has been dissolved by the solvent
Data Source
AI summary
The present disclosure relates to a three-dimensionally (3D) printed tissue engineering scaffold for tissue regeneration and a method for manufacturing the 3D printed tissue engineering scaffold. The 3D printed tissue engineering scaffold may be fabricated at least in part from a composite material having an insoluble component and soluble component. The three-dimensional tissue scaffolds of the disclosure may be fabricated via a rapid prototyping machine. In some instances, the three-dimensional shape of the fabricated tissue engineering scaffold may correspond to a three-dimensional shape of a tissue defect of a patient.